BixBio
PrivateLast Round
Seed
Oct 1, 2021
Momentum
Top 50%
of companies Caplight tracks
Company Overview
BixBio is a biotechnology company that develops bioinformatics software tools to analyze diverse genetic data from African populations for precision medicine and drug discovery.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BixBio Comparables
Compare BixBio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Syndicate Bio | 82% | |
| Galatea Bio Inc. | 78% | |
| Genomics | 76% | |
BixBio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Oct 1, 2021 |
BixBio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Illumina Accelerator | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 19, 2026
Monthly visitors grew 332% MoM, from 290 to 1.3K.
- May 14, 2026
Monthly visitors increased 332% MoM.
BixBio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about BixBio's valuation, stock price, and market status.